Having joined in 2002, Anthony is one of the longest-serving members of our team and is currently a Client Partner with the company. He earned his PhD in pharmacology and biochemistry before becoming a postdoctoral researcher at the University of Southampton. From there, he entered the world of healthcare market research, working for the likes of MMR International, IMS Health (now IQVIA) and NOP World (now GfK). He has consulted across the therapeutic spectrum and throughout the product life cycle; however, at Prescient he particularly enjoys developing clinical strategies in oncology, infectious diseases and cardiometabolic diseases.
Featured
Building Future-Fit MEX Programs for Modern Pharma Marketing
Discover how modern Marketing Excellence programmes help pharma teams build capability, improve decision-making and deliver greater commercial impact.
News and insights
Featured
What’s Next for Oncology? Strategic Perspectives Following ASCO® 2026
What's next for oncology? Strategic Perspectives Following ASCO 2026
Discover The Prescient Pharma Brand Plan Impact Index
Helping senior leaders strengthen strategy and drive better business performance.
The Four Positioning Challenges Every Pharma Launch Team Must Overcome
Discover four positioning challenges that every pharma launch team should address.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
